In this episode, host Laura Jones shines a light on ADHD and the ongoing challenges of diagnosis, treatment, and long-term management. Laura is joined by Jim Potenziano, Vice President of Medical Science and Information at Tris Pharma, for a conversation about the importance of patient education, empowerment, and support in helping individuals and families better navigate ADHD care. The discussion also explores how Tris is working with patients, healthcare professionals, and the wider community to advance disease management, including through delivery technology designed to redefine the way ADHD medications work for patients.